GO
Loading...

Boston Scientific Corp

More

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • Midday Glance: Medical Devices companies Wednesday, 16 Jul 2014 | 2:54 PM ET

    Allergan rose$. 59 or. 4 percent, to $164.97. Baxter International Inc. fell$. 23 or. 3 percent, to $76.53. Boston Scientific Corp. rose$. 09 or. 7 percent, to $12.94.

  • Early Glance: Medical Devices companies Wednesday, 16 Jul 2014 | 11:11 AM ET

    Allergan rose$. 09 or. 1 percent, to $164.47. Baxter International Inc. fell$. 09 or. 1 percent, to $76.67. Boston Scientific Corp. rose$. 07 or. 5 percent, to $12.92.

  • Midday Glance: Medical Devices companies Monday, 14 Jul 2014 | 1:29 PM ET

    Allergan fell$. 34 or. 2 percent, to $166.09. Baxter International Inc. rose$. 03 or percent, to $76.62. Boston Scientific Corp. fell$. 13 or. 9 percent, to $13.17.

  • Early Glance: Medical Devices companies Monday, 14 Jul 2014 | 10:47 AM ET

    Allergan fell$. 82 or. 5 percent, to $165.61. Baxter International Inc. rose$. 20 or. 3 percent, to $76.79. Boston Scientific Corp. fell$. 10 or. 8 percent, to $13.19.

  • Midday Glance: Medical Devices companies Friday, 11 Jul 2014 | 1:37 PM ET

    Allergan rose$. 08 or percent, to $165.68. Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Boston Scientific Corp. fell$. 07 or. 5 percent, to $13.03.

  • Early Glance: Medical Devices companies Friday, 11 Jul 2014 | 10:30 AM ET

    Allergan fell$. 62 or. 4 percent, to $164.98. Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Boston Scientific Corp. fell$. 15 or 1.1 percent, to $12.95.

  • Midday Glance: Medical Devices companies Thursday, 10 Jul 2014 | 1:44 PM ET

    Allergan fell $1.06 or. 6 percent, to $164.14. Baxter International Inc. rose$. 65 or. 9 percent, to $76.47. Boston Scientific Corp. fell$. 01 or. 1 percent, to $13.01.

  • Early Glance: Medical Devices companies Thursday, 10 Jul 2014 | 11:01 AM ET

    Allergan fell $1.32 or. 8 percent, to $163.88. Baxter International Inc. fell$. 10 or. 1 percent, to $75.72. Boston Scientific Corp. fell$. 13 or 1.0 percent, to $12.89.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • Boston Scientific subpoenaed over heart device Friday, 9 May 2014 | 6:25 AM ET
    U.S. Department of Health and Human Services building, Washington, DC.

    Boston Scientific received a subpoena this week from the Department of Health and Human Services seeking information about its defibrillators.

  • Boston Scientific gets subpoena over defibrillators Thursday, 8 May 2014 | 11:37 PM ET

    May 8- Medical device maker Boston Scientific Corp said it received a subpoena this week from the Department of Health and Human Services seeking information about the performance of some of its implanted defibrillators. Boston Scientific, which competes with Medtronic Inc and St. Jude Medical Inc in selling ICDs, said it is cooperating with the request.

  • April 29- Boston Scientific Corp's quarterly revenue fell short of expectations due to lower sales of its implantable defibrillators and pacemakers, sending its shares down as much as 6 percent. Boston Scientific said it expected subcutaneous ICD sales of over $75 million in 2014..

  • Midday movers: Apple, Sprint, Walgreen & More Tuesday, 29 Apr 2014 | 12:06 PM ET

    Some of Tuesday's midday movers:

  • April 29- Boston Scientific Corp reported a better-than-expected adjusted profit in the first quarter, helped by higher sales of its heart catheters and pain-relieving devices, and raised its adjusted earnings forecast for the full year.

  • April 29- Boston Scientific Corp reported a higher adjusted profit in the first quarter, helped by higher sales of its neuromodulation and heart rhythm management devices.

  • April 15- U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.

  • Wall Street analysts had estimated a potential market of $3 billion for the devices made by Medtronic Inc, Boston Scientific Corp and St Jude Medical Inc. But failure of the high-stakes clinical trial set off a heated debate between doctors who believe the approach is worth saving and those who say results show it provides no clear benefit.

  • Hedge funds: It's a stock-pickers market Thursday, 20 Mar 2014 | 11:52 AM ET
    Jacob Gottlieb of Visium

    Stock and bond investment ideas from hedge fund managers at the Absolute Return Symposium in New York.